Greehey CCRI’s Genomic Sequencing Facility to Receive $600,000 NIH Grant to upgrade genomic sequencing capabilities (Lai Lab).
Dr. Zhao Lai, Director of the Genomic Sequencing Facility (GSF) at the Greehey Children’s Cancer Research Institute (Greehey CCRI) at UT Health San Antonio (UTHSA), has been awarded a $600,000 NIH grant to help purchase a new Illumina NovaSeq 6000.
This new system will improve the range of basic, translational, clinical, and genomics studies at UTHSA that depend on affordable, customizable high-throughput next-generation sequencing technologies. It will also improve the high-quality genomic data necessary to support NIH-funded genomic research and enhance various areas, including cancer, aging, pain control, diabetes, immunology, obesity, and neurodegenerative diseases. Investigators will also be able to develop new projects that may take their research in new directions. This equipment will strengthen the GSF’s educational training programs for pre and post-doctoral scientists, physicians, and scientists, and promote continued excellence in genomics and bioinformatics research at UTHSA. The NovaSeq 6000 System will positively impact and expedite many NIH-funded investigations, promote genomic scientific collaborations, and accelerate translational research to improve the health of those in South Texas, a predominantly Hispanic population.
Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, and accelerate the translation of knowledge into novel therapies. Through discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas — research, clinical, and education.